Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Juvista Following Excision of Ear Lobe Keloids
NCT00710333Phase 2Completed
- Sponsor
- Renovo
- Start
- Jul 2008
- Primary completion
- Oct 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of avotermin in keloid, sponsored by Renovo. Started Jul 2008; status: completed.
02
Drugs
avotermin
03
Conditions
keloid
Beyond the preview
Go deeper on NCT00710333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00710333.